Patent Assignment
Reel/Frame 047692/0721
Merger
Recorded: 2018-11-30
Pages: 3
Assignor
NEUROVANCE, INC.
Executed: 2017-11-30
Assignee
OTSUKA AMERICA PHARMACEUTICAL, INC.
2440 RESEARCH BLVD., ROCKVILLE, MARYLAND, 20850
Covered Property
(1)
Novel 1-Aryl-3-Azabicyclo[3.1.0]Hexanes: Preparation and Use to Treat Neuropsychiatric Disorders
Application:
60/703,364 →
PCT:
PCT/US2006/029006 ↗
Related Assignments
(6)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Jul 19, 2007
From: SKOLNICK, PHIL; BASILE, ANTHONY; CHEN, ZHENGMING; EPSTEIN, JOSEPH W.
To: DOV PHARMACEUTICAL, INC.
Reel/Frame 019578/0394 →
Assignment of Assignor's Interest
Aug 19, 2007
From: SKOLNICK, PHIL; CHEN, ZHENGMING
To: DOV PHARMACEUTICAL, INC.
Reel/Frame 019713/0936 →
Merger
Dec 29, 2011
From: DOV PHARMACEUTICAL, INC.
To: EUTHYMICS BIOSCIENCE, INC.
Reel/Frame 027457/0641 →
Assignment of Assignor's Interest
Nov 30, 2018
From: SKOLNICK, PHIL; BASILE, ANTHONY; CHEN, ZHENGMING; EPSTEIN, JOSEPH W.
To: DOV PHARMACEUTICAL, INC.
Reel/Frame 047640/0847 →
Assignment of Assignor's Interest
Nov 30, 2018
From: EUTHYMICS BIOSCIENCE, INC.
To: NEUROVANCE, INC.
Reel/Frame 047692/0651 →
Assignment of Assignor's Interest
Nov 30, 2018
From: EUTHYMICS BIOSCIENCE, INC.
To: NEUROVANCE, INC.
Reel/Frame 047692/0661 →